Wave Life Sciences (WVE) Competitors $14.45 +1.00 (+7.43%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends WVE vs. ASND, RVMD, LNTH, NUVL, LEGN, BPMC, ELAN, CYTK, TGTX, and VKTXShould you be buying Wave Life Sciences stock or one of its competitors? The main competitors of Wave Life Sciences include Ascendis Pharma A/S (ASND), Revolution Medicines (RVMD), Lantheus (LNTH), Nuvalent (NUVL), Legend Biotech (LEGN), Blueprint Medicines (BPMC), Elanco Animal Health (ELAN), Cytokinetics (CYTK), TG Therapeutics (TGTX), and Viking Therapeutics (VKTX). These companies are all part of the "pharmaceutical products" industry. Wave Life Sciences vs. Ascendis Pharma A/S Revolution Medicines Lantheus Nuvalent Legend Biotech Blueprint Medicines Elanco Animal Health Cytokinetics TG Therapeutics Viking Therapeutics Ascendis Pharma A/S (NASDAQ:ASND) and Wave Life Sciences (NASDAQ:WVE) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking. Do insiders & institutionals have more ownership in ASND or WVE? 89.7% of Wave Life Sciences shares are held by institutional investors. 40.0% of Ascendis Pharma A/S shares are held by insiders. Comparatively, 29.1% of Wave Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is ASND or WVE more profitable? Wave Life Sciences has a net margin of -66.50% compared to Ascendis Pharma A/S's net margin of -130.33%. Ascendis Pharma A/S's return on equity of 0.00% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Ascendis Pharma A/S-130.33% N/A -48.77% Wave Life Sciences -66.50%-280.57%-52.90% Does the media prefer ASND or WVE? In the previous week, Ascendis Pharma A/S had 12 more articles in the media than Wave Life Sciences. MarketBeat recorded 19 mentions for Ascendis Pharma A/S and 7 mentions for Wave Life Sciences. Wave Life Sciences' average media sentiment score of 1.44 beat Ascendis Pharma A/S's score of 0.79 indicating that Wave Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascendis Pharma A/S 7 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Wave Life Sciences 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, ASND or WVE? Wave Life Sciences has lower revenue, but higher earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than Wave Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscendis Pharma A/S$327.43M25.98-$521.07M-$8.08-17.36Wave Life Sciences$53.61M41.11-$57.51M-$1.11-13.02 Which has more risk and volatility, ASND or WVE? Ascendis Pharma A/S has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, Wave Life Sciences has a beta of -1.21, suggesting that its share price is 221% less volatile than the S&P 500. Does the MarketBeat Community favor ASND or WVE? Ascendis Pharma A/S received 76 more outperform votes than Wave Life Sciences when rated by MarketBeat users. However, 67.85% of users gave Wave Life Sciences an outperform vote while only 66.52% of users gave Ascendis Pharma A/S an outperform vote. CompanyUnderperformOutperformAscendis Pharma A/SOutperform Votes43966.52% Underperform Votes22133.48% Wave Life SciencesOutperform Votes36367.85% Underperform Votes17232.15% Do analysts rate ASND or WVE? Ascendis Pharma A/S presently has a consensus target price of $191.77, indicating a potential upside of 36.69%. Wave Life Sciences has a consensus target price of $22.22, indicating a potential upside of 53.79%. Given Wave Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Wave Life Sciences is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascendis Pharma A/S 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.92Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryWave Life Sciences beats Ascendis Pharma A/S on 11 of the 19 factors compared between the two stocks. Ad Crypto 101 MediaAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectDiscover our #1 crypto pick before it's too late. Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WVE vs. The Competition Export to ExcelMetricWave Life SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.20B$6.85B$5.14B$9.31BDividend YieldN/A3.06%4.81%4.06%P/E Ratio-13.0210.75135.1817.54Price / Sales41.11287.861,228.03140.34Price / CashN/A56.6540.6537.95Price / Book36.135.394.884.92Net Income-$57.51M$152.04M$118.97M$225.78M7 Day Performance-6.23%-4.32%15.73%-1.58%1 Month Performance12.45%2.80%15.69%6.67%1 Year Performance221.83%17.30%34.73%22.48% Wave Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WVEWave Life Sciences4.9175 of 5 stars$14.45+7.4%$22.22+53.8%+227.7%$2.20B$53.61M-13.02240Positive NewsASNDAscendis Pharma A/S3.2197 of 5 stars$136.47+5.1%$191.77+40.5%+16.0%$8.28B$327.43M-16.52640Short Interest ↑RVMDRevolution Medicines4.6632 of 5 stars$44.68-0.7%$63.67+42.5%+69.6%$7.52B$11.58M-12.54443Positive NewsLNTHLantheus4.4014 of 5 stars$94.50+1.6%$130.00+37.6%+21.9%$6.57B$1.50B15.42834Positive NewsNUVLNuvalent2.3399 of 5 stars$86.53-0.4%$112.60+30.1%+9.7%$6.15BN/A-25.0340Positive NewsLEGNLegend Biotech1.6722 of 5 stars$33.61-4.3%$81.54+142.6%-43.4%$6.14B$520.18M-36.971,800BPMCBlueprint Medicines2.9172 of 5 stars$95.54+2.5%$122.11+27.8%+9.7%$6.07B$249.38M-44.17640Insider TradeShort Interest ↑ELANElanco Animal Health4.2802 of 5 stars$12.18+0.7%$16.75+37.5%-10.5%$6.02B$4.45B30.259,300CYTKCytokinetics3.9849 of 5 stars$49.20+1.1%$83.93+70.6%+32.5%$5.81B$3.22M-9.04250TGTXTG Therapeutics3.8084 of 5 stars$34.75+8.5%$40.67+17.0%+81.7%$5.41B$233.66M-320.17290Positive NewsVKTXViking Therapeutics4.2798 of 5 stars$48.10+2.3%$106.75+121.9%+147.1%$5.36BN/A-51.5620 Related Companies and Tools Related Companies ASND Alternatives RVMD Alternatives LNTH Alternatives NUVL Alternatives LEGN Alternatives BPMC Alternatives ELAN Alternatives CYTK Alternatives TGTX Alternatives VKTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:WVE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WVE Stock Alerts